NHS NEL
Demonstration Formulary
Demonstration Formulary
5 Infections
This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines
Summary of antimicrobial prescribing guidance - managing common infections
05-03-02-02 Cytomegalovirus infection
| Letermovir Prevymis® |
|
Formulary
|
In line with NICE |
 NICE TA591: Letermovir for preventing cytomegalovirus disease after a stem cell transplant |
|
Links
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary)
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA591: Letermovir for preventing cytomegalovirus disease after a stem cell transplant
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
Summary of antimicrobial prescribing guidance - managing common infections